These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 2275278)
41. The use of phospholipid liposomes for lithium administration. Polydipsic effect and tissue distribution of lithium. Zilberman Y; Lichtenberg D; Gutman Y J Pharm Pharmacol; 1979 Sep; 31(9):619-21. PubMed ID: 41065 [TBL] [Abstract][Full Text] [Related]
42. Cell surface receptors in the liver. Jones EA; Vierling JM; Steer CJ; Reichen J Prog Liver Dis; 1979; 6():43-80. PubMed ID: 396566 [No Abstract] [Full Text] [Related]
43. Temperature-dependent drug release from large unilamellar liposomes. Magin RL; Niesman MR Cancer Drug Deliv; 1984; 1(2):109-17. PubMed ID: 6549573 [TBL] [Abstract][Full Text] [Related]
44. Phospholipid composition of small unilamellar liposomes containing melphalan influences drug action in mice bearing PC6 tumours. Large P; Gregoriadis G Biochem Pharmacol; 1983 Apr; 32(7):1315-8. PubMed ID: 6847720 [No Abstract] [Full Text] [Related]
45. Chloroquine-induced accumulation of gangliosides and phospholipids in skeletal muscles. Quantitative determination and characterization of stored lipids. Nilsson O; Fredman P; Klinghardt GW; Dreyfus H; Svennerholm L Eur J Biochem; 1981 Jun; 116(3):565-71. PubMed ID: 7262076 [TBL] [Abstract][Full Text] [Related]
47. Interaction between lectin from Ricinus communis and liposomes containing gangliosides. Surolia A; Bachhawat BK; Podder SK Nature; 1975 Oct; 257(5529):802-4. PubMed ID: 1186866 [No Abstract] [Full Text] [Related]
48. [Liposomes--a future method of drug administration?]. Wislicki L Harefuah; 1977 Jun; 92(12):583. PubMed ID: 885415 [No Abstract] [Full Text] [Related]
49. Liposomes embark on rescue mission to make highly toxic drugs more useful. Raymond CA JAMA; 1987 Mar; 257(9):1143-4. PubMed ID: 3806905 [No Abstract] [Full Text] [Related]
50. Application of drug-containing liposomes to the duration of the intramuscular absorption of water-soluble drugs in rats. Arakawa E; Imai Y; Kobayashi H; Okumura K; Sezaki H Chem Pharm Bull (Tokyo); 1975 Oct; 23(10):2218-22. PubMed ID: 1212751 [No Abstract] [Full Text] [Related]
51. Immunoglobulins as targeting agents for liposome encapsulated drugs. Toonen PA; Crommelin DJ Pharm Weekbl Sci; 1983 Dec; 5(6):269-80. PubMed ID: 6364035 [TBL] [Abstract][Full Text] [Related]
52. Impact of liposomal drug carriers on drug pharmacokinetics. Hunt CA; MacGregor RD J Pharm Sci; 1985 Aug; 74(8):897-8. PubMed ID: 4032278 [No Abstract] [Full Text] [Related]
53. Drug carriers in cardiovascular pharmacology. Caride VJ Adv Cardiol; 1980; 27():114-26. PubMed ID: 7192482 [No Abstract] [Full Text] [Related]
54. Use of monoclonal antibodies and liposomes to improve drug delivery. Present status and future implications. Gregoriadis G Drugs; 1982 Oct; 24(4):261-6. PubMed ID: 7140578 [No Abstract] [Full Text] [Related]
55. The binding of drugs to different polar lipids in vitro. Lüllmann H; Wehling M Biochem Pharmacol; 1979 Dec; 28(23):3409-15. PubMed ID: 533547 [No Abstract] [Full Text] [Related]
56. Fate of lipid and encapsulated drug after intramuscular administration of liposomes prepared by the freeze-thawing method in rats. Ohsawa T; Matsukawa Y; Takakura Y; Hashida M; Sezaki H Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):5013-22. PubMed ID: 3830428 [No Abstract] [Full Text] [Related]
57. [Trends in drug delivery]. Sezaki H Yakugaku Zasshi; 1984 Dec; 104(12):1211-22. PubMed ID: 6085350 [No Abstract] [Full Text] [Related]
58. Liposomes, lipid biophysics, and sphingolipid research: from basic to translation research. Barenholz YC; Peer D Chem Phys Lipids; 2012 May; 165(4):363-4. PubMed ID: 22465210 [No Abstract] [Full Text] [Related]
59. Potential and limitations of drug targeting: an overview. Gardner CR Biomaterials; 1985 May; 6(3):153-60. PubMed ID: 3890975 [TBL] [Abstract][Full Text] [Related]